Malin invests in and supports highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders.
Our purpose is to create shareholder value through the application of long-term capital and strategic support to our investee companies to enable them to reach their value potential.
Vision: To deliver significant returns for our shareholders and transformative outcomes for patients by investing in and supporting highly innovative life sciences companies
2014
Served areaEurope
HeadquartersThe Lennox Building 50 Richmond Street South, D02FK02 Dublin, Leinster 2 – Ireland
IE00BVGC3741
LEI635400JG4YSDU5U1YU17
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryISEQ Overall Index
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.